File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Using glycosylated hemoglobin to define the metabolic syndrome in United States adults

TitleUsing glycosylated hemoglobin to define the metabolic syndrome in United States adults
Authors
KeywordsMedical sciences
Endocrinology
Issue Date2010
PublisherAmerican Diabetes Association. The Journal's web site is located at http://diabetes.diabetesjournals.org/
Citation
The 5th International Symposium on Healthy Aging: Is Aging a Disease?, Hong Kong, 6-7 March, 2010. In Diabetes Care, 2010, v. 33 n. 8, p. 1856-1858 How to Cite?
AbstractOBJECTIVE- To compare the use of GHb and fasting plasma glucose (FPG) to define the metabolic syndrome (MetS). RESEARCH DESIGN AND METHODS- Data from the U.S. National Health and Nutrition Examination Survey 1999-2006 were used. MetS was defined using the consensus criteria in 2009. Raised blood glucose was defined as either FPG ≥100 mg/dl (5.6 mmol/l) or GHb ≥5.7%. RESULTS- In 2003-2006, there was 91.3% agreement between GHb and FPG when either was used to define MetS. The agreement was good irrespective of age, sex, race/ethnicity, BMI, and diabetes status (≥87.4%). Similar results were found in 1999-2002. Among subjects without diabetes, only the use of GHb alone, but not FPG, resulted in significant association with cardiovascular diseases (odds ratio 1.45, P = 0.005). CONCLUSIONS- Using GHb instead of FPG to define MetS is feasible. It also identifies individuals with increased cardiovascular risk. © 2010 by the American Diabetes Association.
Persistent Identifierhttp://hdl.handle.net/10722/126404
ISSN
2015 Impact Factor: 8.934
2015 SCImago Journal Rankings: 5.827
PubMed Central ID
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorOng, KLen_HK
dc.contributor.authorTso, AWKen_HK
dc.contributor.authorLam, KSLen_HK
dc.contributor.authorCherny, SSen_HK
dc.contributor.authorSham, PCen_HK
dc.contributor.authorCheung, BMYen_HK
dc.date.accessioned2010-10-31T12:26:44Z-
dc.date.available2010-10-31T12:26:44Z-
dc.date.issued2010en_HK
dc.identifier.citationThe 5th International Symposium on Healthy Aging: Is Aging a Disease?, Hong Kong, 6-7 March, 2010. In Diabetes Care, 2010, v. 33 n. 8, p. 1856-1858en_HK
dc.identifier.issn0149-5992en_HK
dc.identifier.urihttp://hdl.handle.net/10722/126404-
dc.description.abstractOBJECTIVE- To compare the use of GHb and fasting plasma glucose (FPG) to define the metabolic syndrome (MetS). RESEARCH DESIGN AND METHODS- Data from the U.S. National Health and Nutrition Examination Survey 1999-2006 were used. MetS was defined using the consensus criteria in 2009. Raised blood glucose was defined as either FPG ≥100 mg/dl (5.6 mmol/l) or GHb ≥5.7%. RESULTS- In 2003-2006, there was 91.3% agreement between GHb and FPG when either was used to define MetS. The agreement was good irrespective of age, sex, race/ethnicity, BMI, and diabetes status (≥87.4%). Similar results were found in 1999-2002. Among subjects without diabetes, only the use of GHb alone, but not FPG, resulted in significant association with cardiovascular diseases (odds ratio 1.45, P = 0.005). CONCLUSIONS- Using GHb instead of FPG to define MetS is feasible. It also identifies individuals with increased cardiovascular risk. © 2010 by the American Diabetes Association.en_HK
dc.languageengen_HK
dc.publisherAmerican Diabetes Association. The Journal's web site is located at http://diabetes.diabetesjournals.org/en_HK
dc.relation.ispartofDiabetes Careen_HK
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License-
dc.rightsThis is an author-created, uncopyedited electronic version of an article accepted for publication in TITLE Diabetes Care The American Diabetes Association (ADA), publisher of TITLE, is not responsible for any errors or omissions in this version of the manuscript or any version derived from it by third parties. The definitive publisher-authenticated version is available online at http://dx.doi.org/10.2337/dc10-0190-
dc.subjectMedical sciences-
dc.subjectEndocrinology-
dc.titleUsing glycosylated hemoglobin to define the metabolic syndrome in United States adultsen_HK
dc.typeConference_Paperen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0149-5992&volume=33&issue=8&spage=1856&epage=1858&date=2010&atitle=Using+glycosylated+hemoglobin+to+define+the+metabolic+syndrome+in+United+States+adults-
dc.identifier.emailTso, AWK: awk.tso@gmail.comen_HK
dc.identifier.emailLam, KSL: ksllam@hku.hken_HK
dc.identifier.emailCherny, SS: cherny@hku.hken_HK
dc.identifier.emailSham, PC: pcsham@hku.hken_HK
dc.identifier.emailCheung, BMY: mycheung@hku.hken_HK
dc.identifier.authorityTso, AWK=rp00535en_HK
dc.identifier.authorityLam, KSL=rp00343en_HK
dc.identifier.authorityCherny, SS=rp00232en_HK
dc.identifier.authoritySham, PC=rp00459en_HK
dc.identifier.authorityCheung, BMY=rp01321en_HK
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.2337/dc10-0190en_HK
dc.identifier.pmid20504895-
dc.identifier.pmcidPMC2909078-
dc.identifier.scopuseid_2-s2.0-77958179074en_HK
dc.identifier.hkuros178299en_HK
dc.identifier.hkuros179826-
dc.identifier.hkuros181112-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-77958179074&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume33en_HK
dc.identifier.issue8en_HK
dc.identifier.spage1856en_HK
dc.identifier.epage1858en_HK
dc.identifier.isiWOS:000281422600034-
dc.publisher.placeUnited Statesen_HK
dc.description.otherThe 5th International Symposium on Healthy Aging: Is Aging a Disease?, Hong Kong, 6-7 March, 2010. In Diabetes Care, 2010, v. 33 n. 8, p. 1856-1858-
dc.identifier.scopusauthoridOng, KL=8340854000en_HK
dc.identifier.scopusauthoridTso, AWK=6701371436en_HK
dc.identifier.scopusauthoridLam, KSL=8082870600en_HK
dc.identifier.scopusauthoridCherny, SS=7004670001en_HK
dc.identifier.scopusauthoridSham, PC=34573429300en_HK
dc.identifier.scopusauthoridCheung, BMY=7103294806en_HK
dc.identifier.citeulike8389185-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats